MA55757A - Procédé de préparation de formulations peptidiques stables - Google Patents

Procédé de préparation de formulations peptidiques stables

Info

Publication number
MA55757A
MA55757A MA055757A MA55757A MA55757A MA 55757 A MA55757 A MA 55757A MA 055757 A MA055757 A MA 055757A MA 55757 A MA55757 A MA 55757A MA 55757 A MA55757 A MA 55757A
Authority
MA
Morocco
Prior art keywords
preparing stable
peptide formulations
stable peptide
formulations
preparing
Prior art date
Application number
MA055757A
Other languages
English (en)
Inventor
Gregory Nelson Brown
Scoik Kurt Gard Van
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MA55757A publication Critical patent/MA55757A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
MA055757A 2019-04-26 2020-04-20 Procédé de préparation de formulations peptidiques stables MA55757A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201962839246P 2019-04-26 2019-04-26

Publications (1)

Publication Number Publication Date
MA55757A true MA55757A (fr) 2022-03-02

Family

ID=70554273

Family Applications (1)

Application Number Title Priority Date Filing Date
MA055757A MA55757A (fr) 2019-04-26 2020-04-20 Procédé de préparation de formulations peptidiques stables

Country Status (20)

Country Link
US (1) US20220192988A1 (fr)
EP (1) EP3958838A1 (fr)
JP (2) JP7245926B2 (fr)
KR (1) KR20210143253A (fr)
CN (1) CN113727700A (fr)
AR (1) AR118690A1 (fr)
AU (1) AU2020261941B2 (fr)
BR (1) BR112021018325A2 (fr)
CA (1) CA3134757A1 (fr)
CL (1) CL2021002690A1 (fr)
CO (1) CO2021014034A2 (fr)
EA (1) EA202192475A1 (fr)
EC (1) ECSP21079422A (fr)
IL (1) IL286426A (fr)
MA (1) MA55757A (fr)
MX (1) MX2021012852A (fr)
PE (1) PE20212368A1 (fr)
SG (1) SG11202110413YA (fr)
TW (1) TWI771669B (fr)
WO (1) WO2020219391A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116718762A (zh) * 2023-06-09 2023-09-08 上海品峰医疗科技有限公司 一种多肽类样本稳定剂

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK49791D0 (da) * 1991-03-20 1991-03-20 Novo Nordisk As Nasalt pulverpraeparat
WO2003066669A2 (fr) * 2002-02-04 2003-08-14 Millipore Corporation Procede visant a extraire des agregats de proteines et des virus d'une solution proteinique
US20060074025A1 (en) * 2003-12-26 2006-04-06 Nastech Pharmaceutical Company Inc. Therapeutic formulations for transmucosal administration that increase glucagon-like peptide-1 bioavailability
US7994122B2 (en) 2007-06-15 2011-08-09 Zealand Pharma A/S Glucagon analogues
PL2370462T3 (pl) 2008-12-15 2015-01-30 Zealand Pharma As Analogi glukagonu
US8685919B2 (en) 2008-12-15 2014-04-01 Zealand Pharma A/S Glucagon analogues
CN102292347A (zh) 2008-12-15 2011-12-21 西兰制药公司 胰高血糖素类似物
SI2454282T1 (sl) 2009-07-13 2015-06-30 Zealand Pharma A/S Acilirani glukagonski analogi
JP2013523620A (ja) 2010-03-26 2013-06-17 ノヴォ ノルディスク アー／エス 新規のグルカゴンアナログ
UY33462A (es) 2010-06-23 2012-01-31 Zealand Pharma As Analogos de glucagon
KR20130086343A (ko) 2010-06-24 2013-08-01 질랜드 파마 에이/에스 글루카곤 유사체
CA2839867A1 (fr) 2011-06-22 2012-12-27 Indiana University Research And Technology Corporation Co-agonistes du recepteur du glucagon et du recepteur du gpl-1
US20130316941A1 (en) 2011-12-23 2013-11-28 Boehringer Ingelheim International Gmbh Glucagon analogues
FI124134B (en) 2012-07-02 2014-03-31 One Way Sport Oy Binding between a ski and a ski boot
TWI608013B (zh) 2012-09-17 2017-12-11 西蘭製藥公司 升糖素類似物
US9018162B2 (en) * 2013-02-06 2015-04-28 Xeris Pharmaceuticals, Inc. Methods for rapidly treating severe hypoglycemia
CR20170373A (es) * 2015-02-17 2017-09-18 Lilly Co Eli Formulación en polvo nasal para el tratamiento de hipogligemia

Also Published As

Publication number Publication date
JP2023075249A (ja) 2023-05-30
ECSP21079422A (es) 2021-11-30
EA202192475A1 (ru) 2022-01-28
PE20212368A1 (es) 2021-12-21
US20220192988A1 (en) 2022-06-23
AU2020261941B2 (en) 2023-04-06
AU2020261941A1 (en) 2021-10-14
KR20210143253A (ko) 2021-11-26
CL2021002690A1 (es) 2022-07-08
JP7245926B2 (ja) 2023-03-24
CA3134757A1 (fr) 2020-10-29
JP2022529614A (ja) 2022-06-23
TW202108599A (zh) 2021-03-01
MX2021012852A (es) 2021-12-10
TWI771669B (zh) 2022-07-21
SG11202110413YA (en) 2021-10-28
AR118690A1 (es) 2021-10-27
EP3958838A1 (fr) 2022-03-02
BR112021018325A2 (pt) 2021-11-23
CO2021014034A2 (es) 2021-10-29
IL286426A (en) 2021-10-31
CN113727700A (zh) 2021-11-30
WO2020219391A1 (fr) 2020-10-29

Similar Documents

Publication Publication Date Title
MA53544A (fr) Procédé de préparation de compositions de vaccin
MA52204A (fr) Procédés de préparation de compositions protéiques stables
MA54396A (fr) Procédé de préparation de n-phénylpyrazole-1-carboxamides
EA201791896A1 (ru) Дезацетокситубулизин н и его аналоги
SG11202109277WA (en) Stable protein formulations
EP3761962A4 (fr) Composés excipients pour formulations à base de protéines
EP3998843C0 (fr) Système de traitement de plantes en agriculture
MA55757A (fr) Procédé de préparation de formulations peptidiques stables
MA56055A (fr) Procédés de préparation d'acide 5-bromo-2-(3chloro-pyridin-2-yl)-2h-pyrazole-3-carboxylique
GB2580226B (en) Formulations for hair growth
DK3923914T3 (da) Afabicin-formulering, fremgangsmåde til fremstilling deraf
MA53346A (fr) Composition de vaccin muqueux pour la mastite bovine
IT201900024180A1 (it) Dispositivo per la coltivazione aeroponica di prodotti vegetali
MA49555A (fr) Procédé amélioré de préparation d'imetelstat
IL289637A (en) Plant holder for hydroponic system
DK3911298T3 (da) Formuleringer
DK3781132T3 (da) Apixabanformuleringer
ES1225763Y (es) Soporte para plantas acuaticas helofitas
DK3672926T3 (da) Metode til fremstilling af opløselige gødningsformuleringer
DK3373721T3 (da) Kultiveringsgulvsystem til kultivering af planter
DK3586605T3 (en) Vertical cultivation system for crops
ITUA20161583A1 (it) Giunzione per arcate di contenimento di tutori ortopedici
IT201900003849A1 (it) Macchina defogliatrice per colture filari
ES1245529Y (es) Conjunto perfeccionado de fertilizacion de cultivos
ES1277299Y (es) Dispositivo para la plantación de árboles